‘I’m an optimist,’ says Johnson & Johnson CEO on its R&D investment

CNBC’s Jim Cramer sits down with Johnson & Johnson CEO Joaquin Duato to talk about the company’s outlook, President Trump’s 100% tariff on some pharmaceutical imports, cancer treatment innovation and more.